350 related articles for article (PubMed ID: 24712565)
1. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.
Androulakis II; Kaltsas GA; Kollias GE; Markou AC; Gouli AK; Thomas DA; Alexandraki KI; Papamichael CM; Hadjidakis DJ; Piaditis GP
J Clin Endocrinol Metab; 2014 Aug; 99(8):2754-62. PubMed ID: 24712565
[TBL] [Abstract][Full Text] [Related]
2. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.
Papanastasiou L; Alexandraki KI; Androulakis II; Fountoulakis S; Kounadi T; Markou A; Tsiavos V; Samara C; Papaioannou TG; Piaditis G; Kaltsas G
Clin Endocrinol (Oxf); 2017 Apr; 86(4):488-498. PubMed ID: 27992961
[TBL] [Abstract][Full Text] [Related]
3. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
Araujo-Castro M; Parra Ramírez P; Martín Rojas-Marcos P; García Centeno R; Gracia Gimeno P; Tomé Fernández-Ladreda M; Sampedro Núñez MA; Higueruela C; Robles Lázaro C
Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701
[TBL] [Abstract][Full Text] [Related]
4. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
[TBL] [Abstract][Full Text] [Related]
5. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test.
Arruda M; Mello Ribeiro Cavalari E; Pessoa de Paula M; Fernandes Cordeiro de Morais F; Furtado Bilro G; Alves Coelho MC; de Oliveira E Silva de Morais NA; Choeri D; Moraes A; Vieira Neto L
J Hum Hypertens; 2017 Dec; 32(1):3-11. PubMed ID: 29176595
[TBL] [Abstract][Full Text] [Related]
6. Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and 10-year cardiovascular mortality based on the SCORE algorithm? A study from a single centre in Poland.
Szychlińska M; Rzeczkowska M; Matuszewski W; Bandurska-Stankiewicz E
Endokrynol Pol; 2023; 74(6):. PubMed ID: 37994583
[TBL] [Abstract][Full Text] [Related]
7. The functional status of incidentally discovered bilateral adrenal lesions.
Androulakis II; Kaltsas GA; Markou A; Tseniklidi E; Kafritsa P; Pappa T; Papanastasiou L; Piaditis GP
Clin Endocrinol (Oxf); 2011 Jul; 75(1):44-9. PubMed ID: 21521282
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?
Peppa M; Boutati E; Koliaki C; Papaefstathiou N; Garoflos E; Economopoulos T; Hadjidakis D; Raptis SA
Metabolism; 2010 Oct; 59(10):1435-41. PubMed ID: 20153874
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients' stratification by body mass index and age.
Podbregar A; Janez A; Goricar K; Jensterle M
BMC Endocr Disord; 2020 Jul; 20(1):118. PubMed ID: 32736549
[TBL] [Abstract][Full Text] [Related]
10. Pattern of adrenal hormonal secretion in patients with adrenal adenomas: the relevance of aldosterone in arterial hypertension.
Pappa T; Papanastasiou L; Kaltsas G; Markou A; Tsounas P; Androulakis I; Tsiavos V; Zografos G; Vamvakidis K; Samara C; Piaditis G
J Clin Endocrinol Metab; 2012 Apr; 97(4):E537-45. PubMed ID: 22319028
[TBL] [Abstract][Full Text] [Related]
11. Nonfunctioning Adrenal Incidentalomas are not Clinically Silent: A Longitudinal Cohort Study.
Kim JH; Kim MJ; Lee JH; Yoon JW; Shin CS
Endocr Pract; 2020 Dec; 26(12):1406-1415. PubMed ID: 33471732
[TBL] [Abstract][Full Text] [Related]
12. The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?
Muscogiuri G; Sorice GP; Prioletta A; Mezza T; Cipolla C; Salomone E; Giaccari A; Pontecorvi A; Della Casa S
Clin Endocrinol (Oxf); 2011 Mar; 74(3):300-5. PubMed ID: 21070314
[TBL] [Abstract][Full Text] [Related]
13. Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome.
Emral R; Aydoğan Bİ; Köse AD; Demir Ö; Çorapçıoğlu D
Endocrinol Diabetes Nutr (Engl Ed); 2019; 66(7):402-409. PubMed ID: 30898604
[TBL] [Abstract][Full Text] [Related]
14. Adrenal incidentaloma: Do patients with apparently nonfunctioning mass or autonomous cortisol secretion have similar or different clinical and metabolic features?
Rebelo JFD; Costa JM; Junqueira FD; Fonseca AO; de Almeida ABABS; Moraes AB; Vieira Neto L
Clin Endocrinol (Oxf); 2023 May; 98(5):662-669. PubMed ID: 36514987
[TBL] [Abstract][Full Text] [Related]
15. Markers of Subclinical Cardiovascular Disease in Nonfunctional Adrenal Incidentaloma Patients without Traditional Cardiovascular Risk Factors.
Cansu GB; Sarı R; Yılmaz N; Özdem S; Çubuk M
Exp Clin Endocrinol Diabetes; 2017 Jan; 125(1):57-63. PubMed ID: 27684725
[No Abstract] [Full Text] [Related]
16. Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters.
Akkus G; Evran M; Sert M; Tetiker T
Endocr Metab Immune Disord Drug Targets; 2019; 19(3):326-332. PubMed ID: 30306882
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: a study of 709 cases.
Brox-Torrecilla N; García Cano AM; Valderrábano P; Quintero Tobar A; Escobar-Morreale HF; Araujo-Castro M
Endocrine; 2023 Sep; 81(3):484-491. PubMed ID: 37212980
[TBL] [Abstract][Full Text] [Related]
18. Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.
Araujo-Castro M; Mínguez Ojeda C; Sánchez Ramírez MN; Gómez Dos Santos V; Pascual-Corrrales E; Fernández-Argüeso M
Endocrine; 2022 Oct; 78(1):142-150. PubMed ID: 35751779
[TBL] [Abstract][Full Text] [Related]
19. Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed.
de Paula MP; Moraes AB; de Souza MDGC; Cavalari EMR; Campbell RC; Fernandes GDS; Farias MLF; Mendonça LMC; Madeira M; Bouskela E; Kraemer-Aguiar LG; Vieira Neto L
J Endocrinol Invest; 2021 Mar; 44(3):609-619. PubMed ID: 32686043
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study.
Araujo-Castro M; Casals G; Hanzu FA; Pascual-Corrales E; García Cano AM; Lanza VF; Luis Del Rey Mejías Á; Marchan M; Escobar-Morreale HF; Valderrabano P
Clin Endocrinol (Oxf); 2023 Feb; 98(2):165-176. PubMed ID: 35973974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
